Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Research

• Publication date

  2010-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-09-3470PMID 20442281
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wnt Signaling Is Regulated by Endoplasmic Reticulum Retention

  2009cited by this paper
• 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a Phospholipase D Pharmacological Inhibitor That Alters Cell Spreading and Inhibits Chemotaxis

  2009cited by this paper
• Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.

  2009cited by this paper
• Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways.

  2009cited by this paper
• Lipid signalling in disease

  2008cited by this paper
• TBL1–TBLR1 and β-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis

  2008cited by this paper
• Phorbol Ester Up-regulates Phospholipase D1 but Not Phospholipase D2 Expression through a PKC/Ras/ERK/NFκB-dependent Pathway and Enhances Matrix Metalloproteinase-9 Secretion in Colon Cancer Cells*

  2008cited by this paper
• Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer

  2008cited by this paper
• Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC

  2008cited by this paper
• Expression of phospholipase D2 in human colorectal carcinoma.

  2007cited by this paper
• Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5′ promoter

  2007cited by this paper
• The potential for phospholipase D as a new therapeutic target

  2007cited by this paper
• Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.

  2006cited by this paper
• Requirement of phospholipase D1 activity in H-RasV12-induced transformation.

  2005cited by this paper
• The role of the Wnt signalling pathway in colorectal tumorigenesis.

  2005cited by this paper
• β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation

  2005cited by this paper
• Wnt signaling in disease and in development

  2005cited by this paper
• Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

  2004cited by this paper
• Transmodulation between Phospholipase D and c-Src Enhances Cell Proliferation

  2003cited by this paper
• Chibby, a nuclear β-catenin-associated antagonist of the Wnt/Wingless pathway

  2003cited by this paper
• You Wnt some, you lose some: oncogenes in the Wnt signaling pathway.

  2003cited by this paper
• Tumor formation by genetic mutations in the components of the Wnt signaling pathway

  2003cited by this paper
• Phospholipase D in cell proliferation and cancer.

  2003cited by this paper
• Dynamic Recruitment of NF-Y and Histone Acetyltransferases on Cell-cycle Promoters*

  2003cited by this paper
• Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.

  2003cited by this paper
• Caught up in a Wnt storm: Wnt signaling in cancer.

  2003cited by this paper
• Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway.

  2003cited by this paper
• Phospholipase D-structure, regulation and function.

  2002cited by this paper
• The -Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells

  2002cited by this paper
• The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

  2002cited by this paper
• Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.

  2001cited by this paper
• Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts.

  2001cited by this paper
• Expression and regulation of phospholipase D during neuronal differentiation of PC12 cells.

  2001cited by this paper
• Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein

  2000cited by this paper
• WISP-1 is a Wnt-1- and β-catenin-responsive oncogene

  2000cited by this paper
• Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein.

  2000cited by this paper
• APC truncation and increased beta-catenin levels in a human breast cancer cell line.

  2000cited by this paper
• Increased activity and intranuclear expression of phospholipase D2 in human renal cancer.

  2000cited by this paper
• WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene.

  2000cited by this paper
• Overexpression of phospholipase D1 in human breast cancer tissues.

  2000cited by this paper
• APC truncation and increased β-catenin levels in a human breast cancer cell line

  2000cited by this paper
• The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

  1999cited by this paper
• β‐catenin signaling and cancer

  1999cited by this paper
• The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

  1999cited by this paper
• Phospholipase D activity in human gastric carcinoma.

  1999cited by this paper
• The cyclin D1 gene is a target of the b-cateninyLEF-1 pathway

  1999cited by this paper
• beta-catenin signaling and cancer.

  1999cited by this paper
• Modulation of Transcriptional Regulation by LEF-1 in Response to Wnt-1 Signaling and Association with β-Catenin

  1998cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Beta-catenin mutations in cell lines established from human colorectal cancers.

  1997cited by this paper
• Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma

  1997cited by this paper
• Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells.

  1996cited by this paper
• The APC gene product in normal and tumor cells.

  1993cited by this paper

• The role of phosphatidylcholine metabolism in tumors

  2025cites this paper
• Recent advances in novel targeting mechanisms for colorectal cancer

  2025cites this paper
• PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways

  2024cites this paper
• Decreased Expression of PLD2 Promotes EMT in Colorectal Cancer Invasion and Metastasis

  2024cites this paper
• Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner

  2023cites this paper
• Inhibition of phospholipase D1 induces immunogenic cell death and potentiates cancer immunotherapy in colorectal cancer

  2022cites this paper
• The Role of GnIH in Biological Rhythms and Social Behaviors

  2021cites this paper
• Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer

  2020cites this paper
• Phospholipase D as a key modulator of cancer progression

  2020influential citation
• Application of genetic polymorphism & gene experience of RSPONDIN3 as biomarker of cardiometabolic traits associated with or without obesity in sample of Sudanese patients in Khartoum state.

  2019cites this paper
• MiR-638 suppresses the progression of oral squamous cell carcinoma through wnt/β-catenin pathway by targeting phospholipase D1

  2019cites this paper
• Wnt/β-Catenin Pathway-Regulated Fibromodulin Expression Is Crucial for Breast Cancer Metastasis and Inhibited by Aspirin

  2019cites this paper
• Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment

  2018cites this paper
• miR-497/Wnt3a/c-jun feedback loop regulates growth and epithelial-to-mesenchymal transition phenotype in glioma cells.

  2018cites this paper
• Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.

  2017cites this paper
• Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.

  2017cites this paper
• Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling

  2017cites this paper
• The chromosome 3q26 OncCassette: A multigenic driver of human cancer.

  2016cites this paper
• Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients

  2016cites this paper
• PLD1 regulates Xenopus convergent extension movements by mediating Frizzled7 endocytosis for Wnt/PCP signal activation.

  2016influential citation
• Wnt3a: functions and implications in cancer

  2015cites this paper
• Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells

  2015cites this paper
• DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway

  2014cites this paper
• Phospholipase D in Cell Signaling: From a Myriad of Cell Functions to Cancer Growth and Metastasis*

  2014cites this paper
• Signaling pathways influencing tumor microenvironment and their exploitation for targeted drug delivery

  2014cites this paper
• The Functional Role of Phospholipase D Isozymes in Apoptosis

  2014cites this paper
• Micropallet arrays as an integrated platform for the characterization and manipulation of single cells

  2014cites this paper
• Phospholipase D Signaling Pathways and Phosphatidic Acid as Therapeutic Targets in Cancer

  2014cites this paper
• PLD Signaling as a Phosphoprotein and Its Interaction with Tyrosine Kinases

  2014cites this paper
• Dynamics and evolution of β-catenin-dependent Wnt signaling revealed through massively parallel clonogenic screening.

  2014cites this paper
• Functional Regulation of Phospholipase D Expression in Cancer and Inflammation*

  2014cites this paper
• Phospholipase D1 and choline kinase-α are interactive targets in breast cancer

  2014cites this paper
• Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells

  2013cites this paper
• Predicting mechanism of biphasic growth factor action on tumor growth using a multi-species model with feedback control.

  2013cites this paper
• Macrophage migration arrest due to a winning balance of Rac2/Sp1 repression over β‐catenin‐induced PLD expression

  2013influential citation
• Phenotypes and Karyotypes of Human Malignant Mesothelioma Cell Lines

  2013cites this paper
• Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells

  2013cites this paper
• Wnt Signaling in Remyelination in Multiple Sclerosis: Friend or Foe?

  2013cites this paper
• Phospholipase D1 Has a Pivotal Role in Interleukin-1β-Driven Chronic Autoimmune Arthritis through Regulation of NF-κB, Hypoxia-Inducible Factor 1α, and FoxO3a

  2013cites this paper
• Phospholipase D 1 Has a Pivotal Role in Interleukin-1-Driven Chronic Autoimmune Arthritis through Regulation of NF-B , Hypoxia-Inducible Factor 1 , and FoxO 3 a

  2013cites this paper
• Wnt/β-catenin signalling: from plasma membrane to nucleus.

  2013cites this paper
• Wnt proteins.

  2012cites this paper
• Phospholipase D: enzymology, functionality, and chemical modulation.

  2011cites this paper
• Choline metabolism in malignant transformation

  2011cites this paper
• Phospholipase D meets Wnt signaling: a new target for cancer therapy.

  2011cites this paper